Editorial Team

EDITOR-IN-CHIEF

  1. Jean François Rossi, Jean-François Rossi is Professor of Hematology since 1993. He previously was medical oncologist in the Cancer Center of Montpellier from 1987 and became head of the Hematology Department from 1994 to 2012 at the University Hospital of Montpellier, France. He is now consultant at the University Hospital of Montpellier and at the University Hospital of Nîmes, and was associate professor at Suzhou University (China). Professor Rossi obtained his medical degree and his PhD from the University of Montpellier. He also untertook post-doctoral work at the Cancer Center in Tucson (BGM Durie), at the VUMC San Antonio (GR Mundy) and at the NCI (SA Rosenberg). Professor Rossi was certificated in Rhumatology, Immunology, Medical Oncology, and Hematology. He developed translational research (INSERM U1040, Instiitute of Biotherapy, professor Bernard Klein), particularly targeted therapy, immune therapy for B-cell malignancies, including anti-interleukin 6, anti-BAFF-APRIL anti-HB-EGF therapy, anti-CD20 modulation, cellular therapy, i.e., dendritic cells, T and activated/amplified NK cells from umbilical cord blood with new technology, and identifying active subpopulations (Martin Villalba, INSERM and EEC network CliNK). Professor Rossi is implicated in different scientific advisory boards from innovative start-up companies (BETAINNOV, ORIBASE PHARMA and URODELIA). With BETAINNOV, he participates to new immune functions through the MHC I complex in both dysimmune diseases and hematological malignancies. Professor Rossi is member of the American Society of Hematology, American Society of Clinical Oncology, European Bone Marrow Transplantation and was member of the American Society of Bone and Mineral Research. He is member of the Castleman Disease Collaborative Network (CDCN) scientific advisory board. Professor Rossi has published more than 189 peer-viewed articles in the field of immune therapy, identification of new biological targets in cancer, particularly in B-cell malignancies, in different hematology, immunology and cancer journals. He also serves as reviewer for different jounals in this field of research., France
  2. Xiaochuan Yang, Dr. Xiaochuan Yang is a physician scientist with special interest in hematology/oncology research. With a B.S. in Pharmaceutical Sciences from Peking University (2004) and a PhD in Medicinal Chemistry from Georgia State University (2010), both of his thesis topics were focused on small molecular anti-cancer drug development. The evolving curiosity from chemistry innovation to application led him to pursue clinical pharmacology research at Kimmel Cancer Center at Johns Hopkins later. The 3 years postdoctoral research at Hopkins involved detailed studies of Flt3-mutated AML, its targeted and combination therapy, and its potential resistance mechanism against therapy. His work was presented at the 53rd ASH meeting, and resulted in several pulications on journals including Blood, Oncogene, and British Journal of Haematology. In 2013, Dr. Yang was awarded the Rangos Award for Creativity in Cancer Discovery at Johns Hopkins University. Later, Dr. Yang went to Ben Gurion Univeristy of the Negev in Israel for study in medicine and obtained his MD there in 2017. During his medical school, Dr. Yang has actively rotated in the services of Surgical Oncology in Memorial Sloan Kettering Cancer Center and Hematology in NIH Clinical Center. Right now, Dr. Yang is a resident in Internal Medicine at Mount Sinai St Luke’s- Mount Sinai West Hospital Center, and continuing his journey in the frontier of hematology/oncology research., United States

HONORARY EDITOR-IN-CHIEF

  1. Shimon Slavin, The International Center for Cell Therapy & Cancer Immunotherapy (CTCI), Israel
  2. John M Bennett, Univeristy of Rochester Medical Center, United States
  3. Eva Maria Mischak-Weissinger, Hannover Medical School, Germany
  4. Sheng-Fung Lin, Kaohsiung Medical University Hospital, Taiwan, Province of China
  5. Yusuke Furukawa, Professor of Medicine Division of Stem Cell Regulation Jichi Medical University, Japan

EDITORIAL BOARD MEMBERS

  1. Sameer V.B. Kumar, Central University of Kerala, India
  2. Karina Vidovic, Lund University, Sweden
  3. Barbara Ann Guinn, University of Bedfordshire, United Kingdom
  4. Guang-Biao Zhou, Institute of Zoology, Chinese Academy of Sciences, China
  5. Mudi Misgav, The Tel-Aviv University Sackler School of Medicine, Israel
  6. Imen MOUMNI, Laboratory of Molecular and Cellular Hematology, Pasteur Institute of Tunis,, Tunisia
  7. Jyoti Anand Kode, ACTREC, Tata Memorial Centre, India
  8. Adullah Kürşat Cing, Dicle University School of Medicine, Turkey
  9. Mohamed Ramadan El-Shanshory, Professor of Pediatrics & chairman of Hematology Unit, Tanta University Hospital, Egypt
  10. Avichai Shimoni, Chaim Sheba Medical Center, Israel
  11. Saeed Shoar, Tehran University of Medical Sciences, Iran, Islamic Republic Of
  12. Carmino Antonio De Souza, University of Campinas, Brazil
  13. Antonio Ruggiero, University of Rome, Italy
  14. Georgia D Kaiafa, Aristotle University, Greece
  15. Sevgi Gözdaşoğlu, Pediatric Hematology and Oncology, Turkey
  16. Adullah Kürşat Cingü, Dicle University School of Medicine, Turkey
  17. Leon Bernal-Mizrachi, Winship Cancer Institute of Emory University, United States
  18. Maria Gkotzamanidou, Dana-Farber Cancer Institute – Harvard Medical School, United States
  19. Ya-Wei Qiang, University of Arkansas for Medical Sciences Myeloma Institute, United States
  20. Shiva Razi, Orthopedic Research Center, Mashhad University of Medical Sciences, Iran, Islamic Republic Of
  21. Andrea Di Cataldo, Hospital Policlinico, University of Catania, Italy
  22. ANDY PETROIANU, School of Medicine, Federal University of Minas Gerais, Brazil
  23. Qing Zhang, Sun Yat-sen University, China
  24. PRAVIR KUMAR, Delhi Technological University, India
  25. Tzu-Ching Shih, China Medical University, Taiwan, Province of China
  26. Raveendran I Viji, Central University of Kerala, India
  27. SUBRAMANIYAN RAMANATHAN, Al- Wakra Hospital, Hamad Medical Corporation,, Qatar
  28. Sylvie HERMOUET, Université de Nantes, Nantes, France
  29. Feiyue Xing, Jinan University, China
  30. Shirin Shahbazi, Tarbiat Modares University, Iran, Islamic Republic Of
  31. ROOPAM JAIN, R. D. Gardi Medical College, India
  32. Maxim Leonidovich Filipenko, Institute of Chemical Biology and Fundamental Medicine SB RAS, Russian Federation
  33. Hüseyin Engin, Bülent Ecevit University, Turkey
  34. Tarun Kumar Madan, U N Mehta Institute of Cardiology, India
  35. Raghunadharao Digumarti, Homi Bhabha Cancer Hospital & Research Centre, India
  36. Ahmad Farrag Thabet, Ass.prof. of internal medicine and clinical hematology, Assiut university, Egypt
  37. CHANGGANG LI, Shenzhen Children’s Hospital, China
  38. Louisa G Mahaira, Saint Savvas Cancer Hospital, Greece
  39. Masafumi Ito, Nagoya First Hospital, Japan
  40. Alvin Soon Tiong Lim, Singapore General Hospital, Singapore
  41. PRITI ELHENCE, Sanjay Gandhi Postgraduate Institute of Medical Sciences, India
  42. Maria Luisa Soleadad Sequeira Lopez, University of Virginia, United States
  43. Mang Xiao, Radiation Countermeasures Program, Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, United States
  44. Paloma Ropero, Hospital Clínico San Carlos. Hematology, Spain
  45. Kaoru Okazaki, National Hospital Organization Shikoku Medical Center for Children and Adults, Japan
  46. Kuan-Tsou Lin, Kaohsiung Blood Center, Taiwan Blood Services Foundation, Taiwan, Province of China
  47. Akiyoshi Hagiwara, National Center for Global Health and Medicine, Japan
  48. Akihiro Yokoyama, National Hospital Organization Tokyo Medical Center, Japan
  49. Stephen Bek Ngie Ting, Monash University & Alfred Hospital, Australia
  50. Paul J Higgins, Albany Medical College, United States
  51. Dr CARLOS AGUILAR, Hospital General Santa Bárbara de Soria, Spain
  52. Nader Omidvar, Cardiff School of Medicine, United Kingdom
  53. MAHA ABDULLAH, Universiti Putra Malaysia, Malaysia
  54. Irina Anatol’evna Pashkova, The head of blood transfusion department in Krasnodar regional hospital, the head of Krasnodar regional center of transplantology in Krasnodar regional hospital, Russian Federation
  55. Joan LLuis Vives Corrons, University of Barcelona, Sri Lanka
  56. Kurosh Parsi, St. Vincent’s Hospital Sydney, Australia
  57. Kwok Ming Ho, Royal Perth Hospital and University of Western Australia, Australia
  58. Manish J Gandhi, Mayo Clinic, Rochester MN, United States
  59. Lu Cai, University of Louisville, United States
  60. Der-Cherng Liang, Mackay Memorial Hospital, Taiwan, Province of China
  61. Serena Valsami, University of Athens Medical School, Greece
  62. Shen Meng Gao, The first affiliated hospital of Wenzhou medical university, China
  63. Pedro Ignacio Alvarez, Macopharma Clinical Research Manager, Spain
  64. Maria P Tsantarliotou, Aristotle University of Thessaloniki, Greece
  65. Marina Olegovna Egorova, Russian State Medicine University, Russian Federation
  66. MARIA A MOSCHOVI, University of Athens, Greece
  67. Efthymia Vlachaki, EHA, ASH, Greek Hematology Association, Greece
  68. Eduardo López-Collazo, Head of TumorInmunology Lab and Innate Immunity Group, IdiPAZ, Spain
  69. Eloisa Urrechaga, Osakidetza Servicio Vasco de Salud, Spain
  70. Elena Masselli, Parma University Hospital, Italy
  71. Houyem OURAGINI, Pasteur Institute of Tunis, Tunisia
  72. Yubin Ge, Wayne State University School of Medicine, United States
  73. Nael Alakel, University Hospital Dresden, Germany
  74. Ratana Banjerdpongchai, Chiang Mai University, Thailand
  75. Yaoyu Chen, Nanjing Medical University, China
  76. Kwabena Nsiah, Kwame Nkrumah University of Science and Technology, Ghana
  77. Souvenir D Tachado, Beth Israel Deaconess Medical Center/ Harvard Medical School, United States
  78. Shinichiro Takahashi, Kitasato University School of Allied Health Sciences, Japan
  79. ASHER WINDER, Wolfson Medical Center, Tel-Aviv University,, Israel
  80. George F Babcock, University of Cincinnati, College of Medicine, United States
  81. Mohamed Radhi, Children’s Mercy Hospital, Kansas, United States
  82. Miguel Lopez-Lazaro, University of Seville, Spain
  83. Maria Teresa Di Martino, Magna Graecia University, Italy
  84. Mingqiang Ren, Cancer Center of Georgia Regents University, United States
  85. Ali Aycicek, Istanbul Kanuni Sultan Süleyman Education and Research Hospital, Turkey
  86. Farhad Zaker, Iran university medical sciences, Iran, Islamic Republic Of
  87. Sohier Yahia, Mansoura University Children Hospital, Egypt
  88. Edgar Pick, Tel Aviv University, Israel
  89. Zhixiong Li, Hannover Medical School, Germany
  90. Hiroyuki Miyoshi, Keio University School of Medicine, Japan
  91. Pr. Sophie Paczesny, Indiana University School of Medicine, United States
  92. Tarun Kumar Dutta, Jawaharlal Institute Of Postgraduate Medical Education And Research, India
  93. Katarzyna Aleksandra Lisowska, Medical University of Gdańsk, Poland
  94. Carlos A Tirado, University of California at Los Angeles, United States
  95. Paolo Prandoni, Clinica Medica 2 and Thromboembolism Unit, Chie, University of Padova, Italy
  96. Xiangmin Xu, Southern Medical University, China
  97. GURAY SAYDAM, Ege University, Faculty of Medicine, Turkey
  98. Edgardo Delfino Carosella, Institut Universitaire d’Hematologie, France
  99. Jo Caers, CHU Liège, Belgium
  100. CHARALAMBOS ANTONIADES, University of Oxford, United Kingdom
  101. Paul David Mintz, FDA, United States
  102. MEHMET YILMAZ, Gaziantep University School of Medicine, Turkey
  103. Fakher Rahim, Ahvaz Jundishapur University of Medical Sciences, Iran, Islamic Republic Of
  104. Youchun Wang, National Institutes for Food and Drug Control (NIFDC), China
  105. Tatiana Alekseevna Astrelina, Head of Specialized laboratory cytology, genetics and immunology, Russian Federation
  106. Jian Pan, Children's Hospital of Soochow University, Suzhou, China
  107. Antonella Mameli, Internal Medicine and Haemocoagulopathies, Italy
  108. Lukas Smolej, University Hospital and Charles University in Prague, Czech Republic
  109. Cihan Ay, Medical University of Vienna, Austria
  110. Mona Mohamed Hamdy, Cairo University, Egypt
  111. Mohammad Hadi Sadeghian, Mashhad University of Medical Sciences, Iran, Islamic Republic Of
  112. Mohammad Kazemi Arababadi, Rafsanjan University of Medical Sciences, India
  113. Yong Zhao, Institute of Zoology, Chinese Academy of Sciences, China
  114. XIAOHONG CAI, Medical School of Shanghai Jiao Tong University, China
  115. Hale Aral, Ministry of Health Istanbul Research and Education Hospital, Turkey
  116. Yunping Luo, Chinese Academy of Medical Science & Peking Union Medical College, China
  117. Lee Carpenter, University of Oxford, United Kingdom
  118. Nasim Valizadeh, Tehran University of Medical Sciences, Iran, Islamic Republic Of
  119. Didier Jean-Jacques JAMBOU, Nice Universtiy-Hospitals, France
  120. Shahrbano Rostami, Tehran University of Medical Sciences, Iran, Islamic Republic Of
  121. Yeling Lu, Medical College of Shanghai JiaoTong University, China
  122. Zhinan Yin, International Immunology Center, Jinan University, China
  123. WEI ZHANG, East China Normal University, China
  124. Guangwei Liu, Fudan University, China
  125. Jonathan R Keller, National Cancer Institute, National Institutes of Health, United States
  126. Jean François Rossi, Jean-François Rossi is Professor of Hematology since 1993. He previously was medical oncologist in the Cancer Center of Montpellier from 1987 and became head of the Hematology Department from 1994 to 2012 at the University Hospital of Montpellier, France. He is now consultant at the University Hospital of Montpellier and at the University Hospital of Nîmes, and was associate professor at Suzhou University (China). Professor Rossi obtained his medical degree and his PhD from the University of Montpellier. He also untertook post-doctoral work at the Cancer Center in Tucson (BGM Durie), at the VUMC San Antonio (GR Mundy) and at the NCI (SA Rosenberg). Professor Rossi was certificated in Rhumatology, Immunology, Medical Oncology, and Hematology. He developed translational research (INSERM U1040, Instiitute of Biotherapy, professor Bernard Klein), particularly targeted therapy, immune therapy for B-cell malignancies, including anti-interleukin 6, anti-BAFF-APRIL anti-HB-EGF therapy, anti-CD20 modulation, cellular therapy, i.e., dendritic cells, T and activated/amplified NK cells from umbilical cord blood with new technology, and identifying active subpopulations (Martin Villalba, INSERM and EEC network CliNK). Professor Rossi is implicated in different scientific advisory boards from innovative start-up companies (BETAINNOV, ORIBASE PHARMA and URODELIA). With BETAINNOV, he participates to new immune functions through the MHC I complex in both dysimmune diseases and hematological malignancies. Professor Rossi is member of the American Society of Hematology, American Society of Clinical Oncology, European Bone Marrow Transplantation and was member of the American Society of Bone and Mineral Research. He is member of the Castleman Disease Collaborative Network (CDCN) scientific advisory board. Professor Rossi has published more than 189 peer-viewed articles in the field of immune therapy, identification of new biological targets in cancer, particularly in B-cell malignancies, in different hematology, immunology and cancer journals. He also serves as reviewer for different jounals in this field of research., France
  127. ALAIN MAYINDU NGOMA, Mcgill University, Canada
  128. Ibrahim AYDIN, GATA School of Medicine Department of Biochemistry, Turkey
  129. Giampietro Gasparini, San Filippo Neri Hospital, Italy
  130. Alexandre Arcaro, Inselspital, Bern University Hospital, Switzerland, Switzerland
  131. Ernesto De Meis, Universidade Federal do Rio de Janeiro and Instituto Nacional de Câncer Rio de Janeiro, Brazil
  132. Dr. Dmitry Eduardovich Vybornykh, National Research Center for Hematology, Moscow, Russia, Russian Federation
  133. Ingo Ahrens, Heart Centre, University of Freiburg, Germany
  134. Mikko Olavi Laukkanen, Head of the Research Laboratory, Italy
  135. Sally Mahmoud Shalaby, Zagazig University, Egypt
  136. Shigetaka Shimodaira, Shinshu University Hospital, Japan
  137. UMBERTO GIANELLI, University of Milan, Italy
  138. Philippe Pourquier, INSERM U896, Montpellier Cancer Research Institute, France
  139. Emad Shash, National Cancer Institute, Cairo University, Egypt
  140. Naomasa Yamamoto, School of Pharmaceutical Sciences, Ohu University, Japan
  141. Mitchell Paul DeKoven, IMS Health, United States
  142. Emmanuel Gyan, Teaching hospital of Tours, France
  143. Catherine Lai, National Institutes of Health, National Cancer Institute, United States
  144. Raul Hector Morales-Borges, American Red Cross, Biomedical Services, Region of Puerto Rico, United States
  145. Wenbin Qian, College of Medicine, Zhejiang University, China
  146. Paola Divieti Pajevic, Massachusetts General Hospital, Harvard Medical School, United States
  147. Enqi Liu, Xi’an Jiaotong University Cardiovascular Research Center, China
  148. Xingbin Hu, Xijing Hospital, China
  149. Mohammad Najafi, Iran University of Medical Sciences, Iran, Islamic Republic Of
  150. Herbert Schwarz, National University of Singapore, Singapore
  151. STAVROS K KAKKOS, University of Patras Medical School, Greece
  152. Shaker A Mousa, Executive VP and Chairman Vice Provost, Albany College of Pharmacy and Health Sciences The Pharmaceutical Research Institute, United States
  153. John M Bennett, Univeristy of Rochester Medical Center, United States
  154. Yavuz Memis Bilgin, Admiraal de Ruyter Ziekenhuis, Netherlands
  155. Gangjian Qin, Northwestern University Feinberg School of Medicine, United States
  156. Sumin Kang, Emory University, United States
  157. Anastasios Lymperopoulos, Nova Southeastern University, United States
  158. Tomas Stopka, Charles University in Prague, Czech Republic
  159. Philipp David le Coutre, Charité, Humboldt University Berlin, Germany
  160. MARIA GIULIANA TOZZI CIANCARELLI, University of L’Aquila, Italy
  161. Xinmin Zhang, North Shore-LIJ Health System, United States
  162. Dayong Gao, University of Washington, Seattle, United States
  163. Cezary W Watala, Chair of Biomedical Sciences, Medical University of Lodz, Poland
  164. Suleimman Ahmad Alsweedan, Jordan University of Science & Technology and KFSH&RC, Saudi Arabia
  165. Mariana Kruger, Stellenbosch University, South Africa
  166. Fevzi Altuntas, Yıldırım Beyazıt University, Ankara Oncology Hospital, Turkey
  167. Jinfu Wang, Zhejiang University, China
  168. Timothy A Pritts, University of Cincinnati, United States
  169. Stefan Karlsson, Lund University, Sweden
  170. Amitis Ramezani, Pasteur Institute of Iran, Iran, Islamic Republic Of
  171. Yin Xia, The Chinese University of Hong Kong, Hong Kong
  172. Yan Shi, Shandong University, China
  173. Evan Ingley, Harry Perkins Institute of Medical Research, The University of Western Australia, Australia
  174. JULIO GARCÍA SUAREZ, Príncipe of Asturias University Hospital, Alcala University, Spain
  175. Akshat Jain, Hofstra NorthShore LIJ School of Medicine, United States
  176. Teresa Stachowicz-Stencel, Medical University of Gdansk, Poland
  177. Augusto Pessina, Univerity of Milan, Italy
  178. Gaetano Cairo, University of Milan, Italy
  179. Girish Venkataraman, University of Chicago, United States
  180. Anastasios G Kriebardis, Technological Institute Education (T.E.I.) of Athens, Greece
  181. Khoa Dinh Nguyen, Stanford University, United States
  182. Marian L Kruzel, University of Texas Health Science Center at Houston, United States
  183. Claude Tagny Tayou, University of Yaoundé I, Cameroon
  184. PERIKLIS DOUSDAMPANIS, Hemodialysis Unit Kyanos Stavros Patras,Greece, Greece
  185. Adriana Georgescu, Institute of Cellular Biology and Pathology 'Nicolae Simionescu', Romania
  186. Rania Ali El-Farrash, Ain Shams University, Egypt
  187. BIJU GEORGE, Christian Medical College, Vellore, India
  188. Jiong Hu, Shanghai JiaoTong University, China
  189. Eugene S Kim, University of Southern California, Keck School of Medicine, United States
  190. Jelena Roganovic, Clinical Hospital Centre Rijeka, Croatia
  191. Chieh-Lin Jerry Teng, Taichung Veterans General Hospital, Taiwan, Province of China
  192. Wang Min, United States
  193. Mehmet Kanbay, Koc University School of Medicine, Turkey
  194. Takeshi Matsumura, Kumamoto University, Japan
  195. Pasquale Niscola, Sant'Eugenio Hospital, Italy
  196. Gaëtan Jego, France
  197. Eva Maria Mischak-Weissinger, Hannover Medical School, Germany
  198. Massimo Morfini, AICE (Associazione Italiana Centri Emofilia), Italy
  199. Terrie G Flatt, Children’s Mercy Hospital, United States
  200. Francois Lassailly, Cancer Research UK-London Research Institute, United Kingdom
  201. Jianhua Yu, The Ohio State University, United States
  202. Giovanna Russo, Università di Catania, Italy
  203. Craig S Atwood, University of Wisconsin-Madison, United States
  204. Eduardo Arellano-Rodrigo, Hospital Clínic of Barcelona, Spain
  205. Saleh Mohammed Abdullah, Jazan University, Saudi Arabia
  206. Changcheng Zheng, Anhui Provincial Hospital, China
  207. Javad Zavar Reza, Shahid Sadoughi University of Medical Sciences and Health Services, Iran, Islamic Republic Of
  208. Francyne Kubaski, University of Delaware, United States
  209. Olufemi Akodu, Nigeria
  210. Francyne Kubaski, University of Delaware, United States
  211. Huaizhu Wu, Baylor College of Medicine, United States
  212. BURÇİN TEZCANLI KAYMAZ, Ege University Medical School, Turkey
  213. Konstantinos Konstantopoulos, National And Kapodistrian University Of Athens School Of Medicine, Greece
  214. Salah AbdulWahab Al-Humood, Faculty of Medicine Kuwait University, Kuwait
  215. Rossella Cacciola, University of Catania, Italy
  216. Yusuke Shiozawa, Comprehensive Cancer Center, Wake Forest School of Medicine, United States
  217. Hua Su, University of California, San Francisco, United States
  218. Soon Thye Lim, Head and Senior Consultant Division of Medical Oncology National Cancer Centre Singapore, Singapore
  219. James CS CHIM, Queen Mary Hospital The University of Hong Kong, Hong Kong
  220. RAJENDRA CHAUDHARY, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI), India
  221. Mohammad Hamid, Biotechnology Research Center, Pasteur Institute of Iran, Iran, Islamic Republic Of
  222. Chanchal Rana, Chief of laboratory Dr Lal Path Labs, Lucknow UP, India, India
  223. Hasan A. Abdelghaffar Awad, Mansoura Oncology Center, Mansoura University, Egypt
  224. Dr Evelyne SEGAL-BENDIRDJIAN, INSERM UMR-S 1007 Paris Descartes University, France
  225. Carlos Solano, Head Hematology Hematology and Medical Oncology Department Hospital Clinico Universitario, Spain
  226. Tadeusz Robak, Medical University of Lodz, Poland
  227. Sebastian Grosicki, Head of Department of Hematology, Municipal Hospital in Chorzow, Poland
  228. Jamie Case, Indiana University School of Medicine,, United States
  229. Giovanni Fernando Torelli, Sapienza University, Italy
  230. Yongxin Ru, Institute of Hematology & Blood Diseases Hospital, Peking Union Medical College, China
  231. Florian Christian Lang, Eberhard-Karls-University of Tuebingen, Germany
  232. Yuri V Bobryshev, University of New South Wales, Australia
  233. Joanna Szczepanek, Centre for Modern Interdisciplinary Technologies, Poland
  234. Sheng-Fung Lin, Kaohsiung Medical University Hospital, Taiwan, Province of China
  235. Beata Olas, Faculty of Biology and Environmental Protection, University of Lodz, Poland
  236. Rodrigo Lopes da Silva, Centro Hospitalar Lisboa, Portugal
  237. Wang Rui Tao, the Second Affiliated Hospital, Harbin Medical University, China
  238. Paul Howard Levine, Univ. of Nebraska Medical Center, United States
  239. Vanja Radišić Biljak, Merkur University Hospital, Croatia
  240. Hassan Mansouritorghabeh, Ghaem Hospital, Iran, Islamic Republic Of